HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serologic survey for exposure following fatal Balamuthia mandrillaris infection.

Abstract
Granulomatous amebic encephalitis (GAE) from Balamuthia mandrillaris, a free-living ameba, has a case fatality rate exceeding 90% among recognized cases in the USA. In August 2010, a GAE cluster occurred following transplantation of infected organs from a previously healthy landscaper in Tucson, AZ, USA, who died from a suspected stroke. As B. mandrillaris is thought to be transmitted through soil, a serologic survey of landscapers and a comparison group of blood donors in southern Arizona was performed. Three (3.6%) of 83 serum samples from landscapers and 11 (2.5%) of 441 serum samples from blood donors were seropositive (p = 0.47). On multivariable analysis, county of residence was associated with seropositivity, whereas age, sex, and ethnicity were not. Exposure to B. mandrillaris, previously unexamined in North America, appears to be far more common than GAE in Southern Arizona. Risk factors for disease progression and the ameba's geographic range should be examined.
AuthorsBrendan R Jackson, Zuzana Kucerova, Sharon L Roy, Glenda Aguirre, Joli Weiss, Rama Sriram, Jonathan Yoder, Rebecca Foelber, Steven Baty, Gordana Derado, Susan L Stramer, Valerie Winkelman, Govinda S Visvesvara
JournalParasitology research (Parasitol Res) Vol. 113 Issue 4 Pg. 1305-11 (Apr 2014) ISSN: 1432-1955 [Electronic] Germany
PMID24458652 (Publication Type: Journal Article)
Chemical References
  • Soil
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amebiasis (blood, mortality)
  • Arizona
  • Balamuthia mandrillaris (pathogenicity)
  • Blood Donors
  • Cross-Sectional Studies
  • Encephalitis (blood, mortality)
  • Female
  • Gardening
  • Humans
  • Male
  • Middle Aged
  • Occupational Exposure
  • Risk Factors
  • Seroepidemiologic Studies
  • Soil (parasitology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: